Tourmaline Bio, Inc. (TRML) - Market Value
Tourmaline Bio, Inc. (TRML) is a clinical biotechnologist employing an asset-light approach, where development is conducted in the US while antibody production is outsourced to external facilities. This daily price chart reflects the market value of the company, which currently stands at 1.23. The current focus is centered on testing anti-inflammatory agents, necessitating strict capital monitoring. The efficiency of immunotherapy development is ensured through the extensive outsourcing of all trial stages.
Comprehensive metric breakdowns and analytics for Tourmaline (TRML)
- market price and analyst price targets:
- market capitalization indicators:
- book value of equity indicators:
- debt level and financial liquidity data:
Total Debt to Capital Tourmaline Bio, Inc.|TRML - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Tourmaline Bio, Inc.|TRML - Company Aggregate Debts|Debt to Book Capitalization Ratio Tourmaline|TRML - Company Long-Term Loans and Borrowings|Company Short-Term Debt Tourmaline Bio|Quick Ratio tourmalinebio.com
- business earnings and investment ratios data:
TRML - Net Profit|Future Profit Tourmaline Bio, Inc.|TRML - Company Value to Net Income|Forward P/E Multiple Tourmaline Corp|TRML - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline|TRML - Operating profit before deduction of amortization|Earnings per share for the last twelve months Tourmaline Bio|TRML - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months tourmalinebio.com|TRML - Earnings growth in current year|Net earnings per share growth forecast for next year Tourmaline Bio, Inc.
Fundamental company analysis:TRML (Tourmaline Bio)
The monopoly potential of Tourmaline Bio, Inc. (TRML) within the inelastic demand segment for autoimmune pathology treatments lays the foundation for aggressive business valuation growth. Market capitalization, calculated as the product of the current share price and the number of outstanding shares, digitizes the aggregate monetary valuation of assets, allowing investors to determine the extent of the premium paid for the issuer's future pricing power through the company's capitalization levels.
Key competitors
Market Value argenx ARGX|Market Value BNTX|ABVX - Market Value|ADMA Corp (ADMA) - Market Valuation|Protagonist Therapeutics (PTGX) - Market Value|IMVT (immunovant.com) - Market Value|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|PGEN (Precigen, Inc.) - Market Capitalization|Market Capitalization pharming.com|Market Valuation NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Market Value|Market Capitalization ZBIO (Zenas Biopharma, Inc.)|Market Capitalization Immunome Bio (IMNM)|GOSS - Market Value|kalvista.com (KALV) - Market Valuation|Septerna (SEPN) - Market Value|Market Valuation Pieris Pharma|Market Valuation SVRA|Market Capitalization Rigel Corp|Market Value AnaptysBio, Inc. (ANAB)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|JBIO: Market Valuation|Aclaris Therapeutics, Inc - Market Value|Kyverna Therapeutics (KYTX) - Market Value|Market Value tizianalifesciences.com (TLSA)|Market Valuation CABA|Market Capitalization Ventyx Biosciences Inc.|Market Value Theratechnologies Inc (THTX)|AVTX (Avalo Therapeutics Inc) - Market Value|Market Value Eledon Pharmaceuticals ELDN|AGEN - Market Valuation|Climb Bio - Market Capitalization|ZURA - Market Capitalization|aTyr (ATYR) - Market Value|ADAG (Adagene Inc.) - Market Value|IMA (ImageneBio) - Market Capitalization|Shattuck Therapeutics (STTK) - Market Capitalization|Market Value Equillium, Inc. (EQ)|connectbiopharm.com - Market Capitalization|Market Capitalization IMUX (Immunic)|Atara Biotherapeutics, Inc. (ATRA) - Market Value|IFRX: Market Valuation|Market Value XFOR (x4pharma.com)|ACET: Market Capitalization|CELU (Celularity) - Market Value|INMB (INmune Bio Corp) - Market Capitalization|Barinthus Biotherapeutics Corp (BRNS) - Market Capitalization|Market Value Kezar Life Sciences (KZR)|SABS - Market Value|Akari Therapeutics Plc - Market Valuation|Market Value ENLV|Q32 Bio Corp - Market Capitalization|Market Capitalization GeoVax Corp GOVX|Edesa Biotech, Inc. (EDSA) - Market Value|Market Capitalization IBIO|CARM (Carisma Therapeutics Inc) - Market Capitalization|Market Valuation XTL Biopharmaceuticals Ltd (XTLB)|Market Valuation BOLT (Bolt Biotherapeutics)|Market Capitalization hcwbiologics.com|Aptevo Therapeutics Inc. - Market Valuation|Market Value AIM (aimimmuno.com)|ADTX - Market Value|Market Value GRI (GRI Bio Inc)|XORTX (XRTX) - Market Value|Market Valuation Vyome Therapeutics|Market Value Revelation Biosciences|Market Value INDP|Market Value Scinai Immunotherapeutics Ltd. (SCNI)|CALI: Market Valuation|Market Capitalization AFMD (Affimed N.V.)|Market Value ALLK|HOOKIPA - Market Capitalization|IGMS - Market Capitalization|iTeos Therapeutics, Inc. (ITOS) - Market Value|Ocean Biomedical Inc - Market Value|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
